Blepharitis associated with increased prevalence of lower eyelid ectropion: Study

A recent retrospective study published in the Seminars in Ophthalmology highlighted a notable association between blepharitis and lower eyelid ectropion. The findings analyzed over 35,000 patients from a medical screening center which spanned over 19 years to provide crucial insights for early diagnosis and management of these conditions, especially in older adults.
Blepharitis is an inflammation of the eyelid, affects around 13.2% of adults, while ectropion which is characterized by the outward turning of the lower eyelid, is rarer at just 0.2%. Despite the relatively low prevalence of ectropion, this study emphasized its increased occurrence in patients already diagnosed with blepharitis.
Of the 35,670 patients included in the analysis, 69 were diagnosed with ectropion, while 4,725 were diagnosed with blepharitis. The outcomes found that the prevalence of ectropion was significantly higher (0.8%) among patients with blepharitis when compared to just 0.1% in the group without.
The study also highlighted important demographic patterns. Both conditions were more common in men (88.4% for ectropion and 85% for blepharitis), with age being a critical factor. Ectropion patients had a mean age of 77.3 years and were much older than the average (52.2 years) of general screened population. Also, blepharitis patients had a mean age of 60.5 years.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.